Microbiologists find defense molecule that senses respiratory viruses

Aug 23, 2009
These are side-by-side cross-sections of virus-infected mouse lungs illustrate the critical role of the cellular molecule NOD2 in host defense. The cross-section on the left is from a normal mouse with healthy lungs; the one on the right is from a NOD2-deficient mouse with pneumonia. Credit: Figure courtesy Dr. Santanu Bose laboratory / Nature Immunology

A cellular molecule that not only can sense two common respiratory viruses but also can direct cells to mount a defense has been identified by microbiologists at The University of Texas Health Science Center at San Antonio.

The finding, published online Sunday, Aug. 23, by the journal , could lead to new therapies for human (RSV) and influenza A (commonly known as flu), both of which are serious threats to people with weak immune systems, particularly infants up to age 1 and senior citizens age 65 and older.

"This molecule could be used to boost host immune defenses and stimulate efficacy against RSV and influenza A, especially among high-risk individuals," said senior author Santanu Bose, Ph.D., assistant professor of microbiology and immunology. Dr. Bose's laboratory team includes graduate student Ahmed Sabbath and research scientists Te-Hung Chang and Rosalinda Harnack.

Related to survival

The cellular molecule, called NOD2, recognizes these viruses and can instruct cells to defend against them. Researchers found that mice lacking the sensor survive for only 10 days after infection, compared with up to eight weeks for normal animals.

Identifying this sensor and understanding its key role could result in therapies that activate the NOD2 gene during or prior to infection, leading to enhanced protective immunity. The NOD2 sensor also has the potential to recognize other viruses, such as , yellow fever, Ebola and rabies.

Dr. Bose has multiple grants from the National Institutes of Health and the American Lung Association to continue this line of research. "In the future, studies will gear up to find out if NOD2 is a susceptibility gene for respiratory viruses, since frequent mutation of this gene has been found in humans," he said.

Possible clinical use

Once the study is designed and clinical partner affiliations are reached, the Bose team hopes to draw blood from severely infected, moderately infected and non-infected patients to test for levels of the sensor, which would allow predictions as to how individuals might respond to respiratory viral infections.

"This is a major breakthrough in understanding respiratory virus behavior and innate immune antiviral factors, and provides the basis for innovative therapies to improve host responses to infectious diseases," said Joel Baseman, Ph.D., professor and chairman of microbiology and immunology at the Health Science Center.

Dr. Baseman said microbiology and immunology faculty members in the university's Graduate School of Biomedical Sciences are doing fundamental and translational research that is the basis for the establishment of an airway disease research and vaccine center. The group includes Dr. Bose's co-authors on the NOD2 paper, Peter Dube, Ph.D., and Yan Xiang, Ph.D.

Source: University of Texas Health Science Center at San Antonio

Explore further: Researchers discover new strategy germs use to invade cells

add to favorites email to friend print save as pdf

Related Stories

New agent strikes at respiratory syncytial virus replication

May 05, 2008

University of Texas Medical Branch at Galveston researchers have achieved promising results with a potential new weapon against respiratory syncytial virus, the most common cause of infant hospitalization in the United States.

Scientists solve failed vaccine mystery

Dec 15, 2008

Research led by Johns Hopkins Children's Center scientists has figured out why a respiratory syncytial virus vaccine used in 1966 to inoculate children against the infection instead caused severe respiratory disease and effectively ...

FDA approves new respiratory virus test

Jan 21, 2008

The U.S. Food and Drug Administration has approved a test that detects four respiratory viruses, including the flu, in a patient's respiratory secretions.

Recommended for you

Researchers discover new strategy germs use to invade cells

18 hours ago

The hospital germ Pseudomonas aeruginosa wraps itself into the membrane of human cells: A team led by Dr. Thorsten Eierhoff and Junior Professor Dr. Winfried Römer from the Institute of Biology II, members of the Cluster ...

Progress in the fight against harmful fungi

18 hours ago

A group of researchers at the Max F. Perutz Laboratories has created one of the three world's largest gene libraries for the Candida glabrata yeast, which is harmful to humans. Molecular analysis of the Candida ...

How steroid hormones enable plants to grow

Aug 19, 2014

Plants can adapt extremely quickly to changes in their environment. Hormones, chemical messengers that are activated in direct response to light and temperature stimuli help them achieve this. Plant steroid ...

Surviving the attack of killer microbes

Aug 19, 2014

The ability to find food and avoid predation dictates whether most organisms live to spread their genes to the next generation or die trying. But for some species of microbe, a unique virus changes the rules ...

Histones and the mystery of cell proliferation

Aug 19, 2014

Before cells divide, they create so much genetic material that it must be wound onto spools before the two new cells can split apart. These spools are actually proteins called histones, and they must multiply ...

User comments : 0